Response to Immune Checkpoint Inhibition in Two Patients with Alveolar Soft-Part Sarcoma

Cancer Immunology Research
Jeremy LewinAlbiruni R Abdul Razak

Abstract

Alveolar soft-part sarcoma (ASPS) is a morphologically distinctive mesenchymal tumor characterized by a canonical ASPL-TFE3 fusion product. In the metastatic setting, standard cytotoxic chemotherapies are typically ineffective. Studies have suggested modest clinical response to multitargeted receptor tyrosine kinase inhibitors. Here, we report sustained partial responses in two patients with immune checkpoint inhibition treated with either durvalumab (anti-PD-L1) alone or in combination with tremelimumab (anti-CTLA-4), which appeared unrelated to tumor immune infiltrates or mutational burden. Genomic analysis of these patients, and other cases of ASPS, demonstrated molecular mismatch-repair deficiency signatures. These findings suggest that immune checkpoint blockade may be a useful therapeutic strategy for ASPS. Cancer Immunol Res; 6(9); 1001-7. ©2018 AACR.

References

Jul 12, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P ReichardtB Dörken
Jul 17, 2003·British Journal of Cancer·K J RoozendaalB B R Kroon
Aug 22, 2003·Oncology·S PostovskyM W Ben Arush
Nov 6, 2004·Disease Markers·Jeffery W BacherStephen N Thibodeau
Dec 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alexander J F LazarDina Lev
Jan 19, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S StacchiottiS Pilotti
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Mar 8, 2014·Oncoimmunology·Stéphane ChampiatJean Charles Soria
Apr 10, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ian JudsonMichael Leahy
Jan 23, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hojabr KakavandRichard A Scolyer
Mar 24, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric BouffetUri Tabori
Mar 14, 2017·Nature Medicine·Helen DaviesSerena Nik-Zainal
Dec 20, 2017·Journal for Immunotherapy of Cancer·Roman GroisbergVivek Subbiah

❮ Previous
Next ❯

Citations

Nov 20, 2018·F1000Research·Jennifer Choe, Richard Riedel
Jul 23, 2019·PLoS Pathogens·Riddhima BangaMatthieu Perreau
Apr 5, 2020·Veterinary and Comparative Oncology·Matthew J AthertonNicola J Mason
Jun 21, 2019·Pediatrics International : Official Journal of the Japan Pediatric Society·Maria LeszczynskaS Alex Rottgers
Jul 14, 2019·Nature Reviews. Cancer·David T W JonesStefan M Pfister
Nov 30, 2018·International Journal of Molecular Sciences·Kenji Nakano, Shunji Takahashi
Jul 30, 2020·Cancers·Mateusz Jacek SpałekPiotr Rutkowski
Jul 1, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Javier Martín-BrotoBrian A Van Tine
Jan 25, 2021·QJM : Monthly Journal of the Association of Physicians·Mauro VasellaBong-Sung Kim
Dec 17, 2020·Cancers·Mieszko LachotaKarl-Johan Malmberg
Nov 19, 2020·Journal for Immunotherapy of Cancer·Javier Martin-BrotoJose A Lopez-Martin
Nov 2, 2020·Cancer Treatment Reviews·Mayanne M T ZhuTorsten O Nielsen
Jul 22, 2021·Current Problems in Cancer·Geraldine O'Sullivan CoyneAlice P Chen
Aug 17, 2021·Medicine·Xiaojing ChangLiubing Hou
Aug 28, 2021·Biomedicines·Siddh van OostNoel F C C de Miranda
Apr 8, 2021·Histopathology·Suk Wai LamJudith V M G Bovée

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Rocky Mountain Medical Journal
S A Reynolds, W K Solonar
Bulletin of the Osaka Medical School
S Kondo
The Journal of Bone and Joint Surgery. American Volume
A E BrodskyW R Sassard
American Journal of Ophthalmology
O Litricin
© 2022 Meta ULC. All rights reserved